Related Experiment Videos
Response of human colon carcinoma xenografts to recombinant human tumor necrosis factor (TNF)
R Osieka1, P Glatte, N Niederle
1Department of Medical Oncology, University of Essen.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
Patient preferences and travel burden before radiotherapy for primary cutaneous lymphoma: baseline results from the S-MISR registry.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Comparative toxicity and efficacy of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: real-world retrospective cohort study.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Evaluation of PET-detected nodal upstaging and planning target volume expansion in esophageal cancer radiotherapy planning.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Increased number of chemotherapy cycles during radiochemotherapy improves overall survival without increasing toxicity in locally advanced non-small cell lung cancer patients.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Tightening the gradient: ten years of dosimetric refinement in head and neck reirradiation.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Outcomes in long-term survivors treated with stereotactic cranial radiotherapy for brain metastases.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodeling.
Frontiers in cell and developmental biology·2026
Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death.
Frontiers in immunology·2026
Efficacy of the Peritoneovenous Shunt as Palliative Care for Patients with Advanced Cancer with Refractory Ascites: A Randomized Controlled Trial (JIVROSG-0803 Study).
Interventional radiology (Higashimatsuyama-shi (Japan)·2026